PMO-23 Treatment persistence rates with Tofacitinib in a real-world cohort of anti-TNF refractory ulcerative colitis patients
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI